Pharmacokinetics and converting enzyme inhibition after morning and evening administration of oral enalapril to healthy subjects.
Possible circadian changes in the pharmacokinetics and effect on serum angiotensin-converting enzyme (ACE) activity of the ACE inhibitor enalapril have been studied in 8 healthy subjects after oral ingestion of 10 mg enalapril maleate either at 08.00 h or 20.00 h. The time to peak serum concentration (tmax) of enalapril was increased after administration at 20.00 h compared to 08.00 h (2.4 h versus 1.3 h), whereas other kinetic parameters were not significantly altered. The 24 h-kinetics of the active metabolite enalaprilat did not differ significantly between the two treatments, but the area under the curve (AUC (0-24] and the peak serum concentration (Cmax) were slightly higher after intake at 20.00 h. The relationship between the measured serum enalaprilat level and the degree of inhibition of serum ACE was the same after both treatments. Overall, the evening and morning administration of enalapril did not differ markedly in the pharmacokinetics and the time course of ACE inhibition.
Weisser
K
K
Zentrum der Pharmakologie, Klinikum der Universität, Frankfurt, Federal Republic of Germany.
Schloos
J
J
Lehmann
K
K
Düsing
R
R
Vetter
H
H
Mutschler
E
E
D000284:Administration, Oral; D000328:Adult; D002940:Circadian Rhythm; D004656:Enalapril / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology; D005260:Female; D006801:Humans; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000097:blood
D004656:Enalapril; D007703:Peptidyl-Dipeptidase A